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Valorisation 
In this chapter, the relevance of this thesis for researchers, policymakers and the general 
public will be discussed. Scientific work should benefit not only the scientific community; it is 
more important than ever to translate the value of scientific work into ideas and solutions for 
problems which societies face, and to evolve beyond these to create a more sustainable, 
healthy and wealthy society. In this context, this chapter provides some ideas and activities, 
and concludes with a description of the dissemination of the findings of this thesis. 
Relevance for researchers 
The main relevance of this thesis for researchers lies in the new tools which support the 
identification, classification, and valuation of the intersectoral costs and benefits (ICBs) of 
health interventions. These tools are generic enough to be applied in various fields of 
health research, including preventive, cure, and care interventions. By using the 
classification scheme for ICBs and methods for valuing ICBs, a more complete economic 
evaluation can be conducted from the societal perspective. Furthermore, the classification 
scheme also creates more awareness of the diversity of costs and benefits which may result 
from a health change. These tools can therefore be seen as guidelines for improving the 
quality of costing research, and economic evaluations. The applications of these tools in 
the economic evaluations which are presented in this thesis are but the first; these studies 
can be used as examples for other researchers who are interested in conducting economic 
evaluations which include ICBs, both inside and outside the Netherlands. Furthermore, this 
thesis may function as a basis for future research into ICBs, such as investigating the 
specificity of ICBs for certain diseases, but also research into tools which support the 
measurement of ICBs. 
Research into these ICBs may bridge policy gaps between sectors, especially at the 
national level, and is also crucial in reflecting the true societal value of decisions outside 
the healthcare sector. One such overarching tool for which ICBs could be relevant is the 
societal cost-benefit analysis (SCBA). The SCBA is an ex ante type of analysis in which the 
expected impact of a policy measure is projected. In the Netherlands, this type of analysis 
has been used for infrastructural projects for years, and has come to be an important tool 
for supporting healthcare decision making as well. In a letter to the Dutch House of 
Representatives in December 2013 (IRF/2013/993), the Minister of Finance, Jeroen 
Dijsselbloem, presented a new generic guideline on SBCA, which was written by the 
Netherlands Bureau for Economic Policy Analysis (CPB, or ‘Centraal Planbureau’) and the 
Netherlands Environmental Assessment Agency (PBL, or ‘Planbureau voor de 
Leefomgeving ‘). The year after, the National Institute for Public Health and the 
Environment (RIVM, or ‘Rijksinstituut voor Volksgezondheid en Milieu’), published a 
thematic report on the role of SCBAs for the healthcare sector and public health. Costing 
data, such as unit prices related to ICBs, could be supportive in conducting such SCBAs. 
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It is important to use an intersectoral approach when it comes to health-related 
research, as health is intertwined with all aspects of everyday life. This thesis presents 
studies which were aimed at gaining insight into the ICBs of health(care) interventions. In 
practice, however, the interaction and consequences can also come from the other 
direction, so to speak; interventions outside the healthcare sector might lead to costs and 
benefits inside the healthcare sector. This means that it is important to investigate the effect 
of a health change not only in the case of a health(care) intervention, but also the effect  on 
health when an intervention is primarily aimed at other sectors.  An example of a tool which 
can be used to calculate this effect is the health effect screening, or GES 
(‘gezondheidseffectscreening’). In the GES, the impact of a non-health policy measure or 
decision by the national or a local government, company or other decision-maker on 
population health is investigated. One such application of this tool is the assessment of the 
impact on health of various types of transportation, such as air traffic. Important 
stakeholders in the GES are the Ministry of Health, Welfare and Sport, the Ministry of 
Infrastructure and the Environment, and local governments. When it comes to ICBs, even 
more stakeholders could play a vital role, such as the Ministry of Education, Culture and 
Science, and the Ministry of Security and Justice, as many ICBs of health interventions 
might end up in their policy domain. 
Relevance for policymakers and society  
Several policymakers who were consulted as experts during this research project 
acknowledged the important role of ICBs in decision-supportive information. Improved 
decision-supporting information leads to improved decision-making. Health insurers, 
pharmaceutical companies, and public policy makers could consult this thesis, for it may be 
helpful for decision-making processes. For example, research into ICBs may lead to 
improved reimbursement decisions, but it may also benefit decisions when setting out 
research. Insights into ICBs disclose the payers and beneficiaries of such decisions and 
show the proportional distributions of costs and benefits among these. Furthermore, this 
thesis could be supportive for Health in All Policies (HiAP) initiatives. Decision-makers who 
are operating outside the health domain need reasons for investing in health. If the returns 
on investments for their own domain, e.g. education or the justice system, can be 
quantified, this might give a boost to HiAP. 
In the end, developments in the scientific world and policy changes affect society’s 
health. Prevention, cure and care are derived demands. These are but pathways to create 
or maintain health, and health is life. If ICBs change the outcome of an economic 
evaluation and if this economic evaluation weighs heavily in the decision-making process 
on whether or not an intervention is worth paying for, the relevance of paying attention to 
ICBs becomes very clear. 
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Dissemination of knowledge 
Reflecting on the efforts which have been made to disseminate the results of this 
dissertation, these have been quite extensive already. The lead author and co-authors of 
the studies which are presented in this thesis have put much effort into disseminating the 
results of their work alongside the writing of this thesis, instead of waiting for the thesis to be 
finished. Between 2013 and 2016, four out of five chapters were published in 
international peer-reviewed impact journals. Of these, three were published ‘open access’, 
which means that these are publically and freely available to whomever is interested in 
these studies. Open access publishing has been made one of the top priorities of the Dutch 
Secretary of State, Sander Dekker. In a letter to the Dutch House of Representatives in 
November 2013 (31288-354), he defends the open access initiative by stating that 
publically funded research should be publically available.  
Apart from these publications, a Dutch guideline on ICBs was published in 2014, 
which supports Dutch researchers and policymakers in conducting and assessing costing 
research and economic evaluations from the societal perspective. This work has now been 
cited in the new 2015 guideline on costing research of the Netherlands Healthcare 
Institute. Dutch studies and debates on this work have been published or are accepted for 
publication in ‘Tijdschrift voor Psychiatrie’ and ‘Tijdschrift voor Gezondheids-
wetenschappen’. Furthermore, results of the various studies have been presented at fifteen 
conferences and symposia, within and outside the Netherlands. One of these was a 
symposium on ICBs and SCBA at the Dutch Ministry of Health, Welfare and Sport in 
October 2014. During these conferences and symposia, the audience had the opportunity 
to provide feedback. The same goes for the guideline, which is freely available and can 
still be commented on via an online questionnaire on the website of the Department of 
Health Services Research of Maastricht University. Feedback can be used for this type of 
research to evolve and to improve guidelines for the future of health economics. 
Opportunities for spreading the results are specified in a dissemination plan. This plan, 
which was presented to the Netherlands Organisation for Health Research and 
Development, provides an overview of strategies for the dissemination and implementation 
of the products resulting from this research project, including activities related to publishing, 
presenting and spreading knowledge on ICBs through education. Finally, this work can be 
used to educate not only students, but also policymakers on both the national and local 
levels. This is necessary, for health economics is becoming more and more important in 
healthcare decision-making, and well-informed decision-making will lead to better 
population health. 
 
 
